A recent case–control retrospective study has shown that DDIs involving DOACs were linked to an increased risk of bleeding when associated with combined P-gp/CYP3A4 inhibitors and were linked to a higher risk for stroke and systemic emboli when associated with CYP3A4 inducers [26]. This evidence concerns the gene PGP and stroke disorder.